A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061

by Deeken John F, Rudek Michelle A, Moore Page C, Aboulafia David, Sullivan Ryan, Gerecitano John, Cianfrocca Mary, Henry David, Ratner Lee, Dezube Bruce, Mosby Kimberly, Tibbals Melinda, Little Richard F, Ivy S P, Mitsuyasu Ronald T
Published 2012-04-01

Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

by Davids, Matthew S., Roberts, Andrew W., Seymour, John F., Pagel, John M., Kahl, Brad S., Wierda, William G., Puvvada, Soham, Kipps, Thomas J., Anderson, Mary Ann, Salem, Ahmed Hamed, Dunbar, Martin, Zhu, Ming, Peale, Franklin, Ross, Jeremy A., Gressick, Lori, Desai, Monali, Kim, Su Young, Verdugo, Maria, Humerickhouse, Rod A., Gordon, Gary B., Gerecitano, John F.
Published 2017